Organon & Co. (NYSE:OGN) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Organon Fourth Quarter and Full Year 2025 Earnings Call and webcast. [Operator Instructions].
Organon & Co. (OGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 8,570,958 | $61,282,347 | +106% | 0.03% |
| 2. | Kahn Brothers Irving Kahn | 3,629,451 | $26,023,163 | +1% | 4.61% |
| 3. | Sio Capital Michael Castor | 3,421,765 | $24,534,055 | 3.86% | |
| 4. | D E Shaw D. E. Shaw | 3,386,724 | $24,282,811 | +590% | 0.01% |
| 5. | Gotham Asset Management Joel Greenblatt | 2,653,817 | $19,027,868 | -29% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.67 | 65,400 | $501,755.34 | 77,869 | 2025-11-12 | Filing | |
| $8.07 | 12,469 | $100,591.16 | 12,469 | 2025-05-14 | Filing | |
| $8.77 | 5,500 | $48,235.00 | 62,974 | 2025-05-07 | Filing | |
| $9.21 | 8,045 | $74,054.23 | 52,489 | 2025-05-06 | Filing | |
| $8.24 | 3,500 | $28,828.10 | 46,669 | 2025-05-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 36,916,382 | $264,690,458 | 0% | |
| 2. | 30,966,019 | $222,026,355 | 0% | |
| 3. | 9,597,761 | $68,815,946 | 0% | |
| 4. | 6,882,166 | $49,345,130 | 0.02% | |
| 5. | 4,600,477 | $32,992,346 | 0% |
News See All
Organon & Co. (OGN) Climbs 13.7% Ahead of Dividends
Organon extended its winning streak to a third straight day on Monday, jumping 13.72 percent to close at $7.71 as investors snapped up shares ahead of the record date for its next quarterly dividend payment...
Organon & Co. (NYSE:OGN) Q3 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Organon Third Quarter 2025 Earnings Call and Webcast.
Jim Cramer's "Worst Stock Ever" Might Be Organon (OGN)
Organon & Co. (NYSE:OGN) is a women’s health company that provides fertility and contraceptive products.
11 Stocks Jim Cramer Discussed, Including A Potential "Worst Stock Ever"
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed AI, jobs, and the housing market. Discussing coverage in the Financial.
12 Cheap Healthcare Stocks to Buy Now
Mizuho health care sector strategist Jared Holz made an appearance on CNBC's "The Exchange" on July 21 to discuss the challenges facing the healthcare industry and whether there are any opportunities ...
Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health Portfolio
Organon & Co. (NYSE:OGN) is a pharmaceutical company focused on women’s health and biosimilars.
10 Overlooked Healthcare Stocks to Invest in
Most Americans have endured the frustration of having their health insurance denied, often with no resolution even after contacting carriers by phone and email. This can be changed by Dr.
Organon & Co. (OGN) Reports Q2 2025 Results
Organon & Co. (NYSE:OGN) is one of the top oversold NYSE stocks to buy now. Organon & Co.
Hedge Fund Resource Center